Pregnancy-associated plasma protein A in obese children: Relationship to markers and risk factors of atherosclerosis and members of the IGF system

European Journal of Endocrinology

Volumn 165, Issue 4, 2011, Pages 613-622

  Woelfle, Joachim ^a   Roth, Christian L ^b   Wunsch, Rainer ^c   Reinehr, Thomas ^c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BEHAVIOR THERAPY; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR RISK; CAROTID ARTERY; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; KINESIOTHERAPY; LEAN BODY WEIGHT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; OUTPATIENT CARE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; LINEAR MODELS; LIPIDS; LONGITUDINAL STUDIES; MALE; OBESITY; OVERWEIGHT; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PUBERTY; RISK FACTORS; SOMATOMEDINS; WEIGHT LOSS;

EID: 80053557138     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0423     Document Type: Article

References (46)

1. Lin TM, Halbert SP, Kiefer DJ, Spellacy WN & Gall S. Characterization of four human pregnancy-associated plasma proteins. American Journal of Obstetrics and Gynecology 1974 118 223-236.
2. Wald NJ, Watt HC & Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. New England Journal of Medicine 1999 12 461-467. (doi:10.1056/ NEJM199908123410701)
3. Overgaard MT, Oxvig C, Christiansen M, Lawrence JB, Conover CA, Gleich GJ, Sottrup-Jensen L & Haaning J. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biology of Reproduction 1999 61 1083-1089. (doi:10.1095/biolreprod61.4.1083)
4. Chen B-K, Leiferman KM, Pittelkow MR, Overgaard MT, Oxvig C & Conover CA. Localization and regulation of pregnancy-associated plasma protein-A expression in healing human skin. Journal of Clinical Endocrinology and Metabolism 2003 88 4465-4471. (doi:10.1210/jc.2003-030193)
5. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, Virmani R, Oxvig C & Schwartz RS. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. New England Journal of Medicine 2001 345 1022-1029. (doi:10.1056/NEJMoa003147)
6. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR III & Conover CA. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. PNAS 1999 96 3149-3153. (doi:10.1073/pnas.96.6.3149)
7. Monget P, Mazerbourg S, Delpuech T, Maurel MC, Maniere S, Zapf J, Lalmanach G, Oxvig C & Overgaard MT. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: Identification of cleavage site and characterization of IGFBP-2 degradation. Biology of Reproduction 2003 68 77-86. (doi:10.1095/biolreprod.102.007609)
8. Rivera GM & Fortune JE. Selection of the dominant follicle and insulin-like growth factor (IGF)-binding proteins: evidence that pregnancy-associated plasma protein A contributes to proteolysis of IGF-binding protein 5 in bovine follicular fluid. Endocrinology 2003 144 437-446. (doi:10.1210/en.2002-220657)
9. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA & Oxvig C. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Letters 2001 504 36-40. (doi:10.1016/S0014-5793(01)02760-0)
10. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Füchtbauer E-M, Oxvig C & van Deursen J. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004 131 1187-1194. (doi:10.1242/dev. 00997)
11. DeChiara TM, Efstratiadis A & Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990 345 78-80. (doi:10.1038/345078a0)
12. Rehage M, Mohan S, Wergedal JE, Bonafede B, Tran K, Hou D, Phang D, Kumar A & Qin X. Transgenic overexpression of pregnancy-associated plasma protein-A increases the somatic growth and skeletal muscle mass in mice. Endocrinology 2007 148 6176-6185. (doi:10.1210/en.2007-0274)
13. Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P & Pulkki K. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003 108 1924-1926. (doi:10.1161/01.CIR.0000096054.18485.07)
14. Iversen KK, Dalsgaard M, Teisner AS, Schoos M, Teisner B, Nielsen H, Clemmensen P & Grande P. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome. American Journal of Cardiology 2009 104 1465-1471. (doi:10.1016/j.amjcard.2009.07.017)
15. Heider P, Pfäffle N, Pelisek J, Wildgruber M, Poppert H, Rudelius M & Eckstein HH. Is serum pregnancy-associated plasma protein A really a potential marker of atherosclerotic carotid plaque stability ? European Journal of Vascular and Endovascular Surgery 2010 39 668-675. (doi:10.1016/j.ejvs.2010. 03.012)
16. Domínguez-Rodríguez A, Abreu-González P, García-González M, Ferrer J & Vargas M. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction. Clinical Biochemistry 2005 38 180-182. (doi:10.1016/j.clinbiochem. 2004.10.015)
17. Qin QP, Kokkala S, Lund J, Tamm N, Qin X, Lepäntalo M & Pettersson K. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clinical Chemistry 2006 52 398-404. (doi:10.1373/clinchem.2005.058396)
18. Aso Y, Okumura K, Wakabayashi S, Takebayashi K, Taki S&Inukai T. Elevated pregnancy-associated plasma protein-A in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. Journal of Clinical Endocrinology and Metabolism 2004 89 5713-5717. (doi:10.1210/jc.2004-0787)
19. Pellitero S, Reverter JL, Pizarro E, Pastor MC, Granada ML, Tassies D, Reverter JC, Salinas I & Sammarti A. Pregnancy-associated plasma protein-A levels are related to glycemic control but not to lipid profile or hemostatic parameters in type 2 diabetes. Diabetes Care 2007 30 3083-3085. (doi:10.2337/dc07-1092)
20. Reinehr T, Kiess W, De Sousa G, Stoffel-Wagner B & Wunsch R. Intima media thickness in childhood obesity relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism: Clinical and Experimental 2006 55 113-118. (Pubitemid 41736256)
21. Reinehr T, Kiess W, Kapellen T & Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004 114 1569-1573. (doi:10.1542/peds.2003-0649-F)
22. Reinehr T, De Sousa G, Toschke AM & Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. American Journal of Clinical Nutrition 2006 84 490-496. (Pubitemid 44713397)
23. Cole TJ, Bellizzi MC, Flegal KM & Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000 320 1240-1243. (doi:10.1136/bmj.320.7244.1240)
24. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Ziegler A, Geiß HC, Hesse V, Hippel A, Jäger U, Johnsen D, Kiess W, Korte W, Menner K, Müller M, Niemann-Pilatus A, Remer T, Schäfer F, Wittchen HU, Zabransky S, Zellenr K & Hebebrand J. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001 149 807-818. (doi:10.1007/s001120170107)
25. Cole TJ. The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition 1990 44 45-60. (Pubitemid 20177198)
26. Marshall WA & Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood 1969 44 291-303. (doi:10.1136/adc.44. 235.291)
27. Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood 1970 45 13-23. (doi:10.1136/adc.45.239.13)
28. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004 114 555-576. (doi:10.1542/peds.114.2.S2.555)
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
30. Hurwitz Eller N & Netterstrom B. The intima media thickness and coronary risk factors. International Angiology 2001 20 118-125. (Pubitemid 32988385)
31. Simon A, Gariepy J, Chironi G, Megnien JL & Levenson J. Intimamedia thickness: a new tool for diagnosis and treatment of cardiovascular risk. Journal of Hypertension 2002 20 159-169. (doi:10.1097/00004872-200202000-00001)
32. Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JS, Hartiala JJ & Raitakari OT. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000 36 929-933.
33. Beaudeux JL, Burc L, Imbert-Bismut F, Giral P, Bernard M, Bruckert E & Chapman MJ. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 e7-10. (doi:10.1161/01.ATV.0000047448. 76485.B8)
34. Harrington SC, Simari RD & Conover CA. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a highfat diet. Circulation Research 2007 22 1696-1702. (doi:10.1161/CIRCRESAHA.106.146183)
35. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone & IGF Research 2003 13 113-170. (doi:10.1016/S1096-6374(03)00038-8)
36. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A & Gibson JM. Close relation of fasting insulin-like growh factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 2001 44 333-339. (doi:10.1007/s001250051623)
37. Motaghedi R, Gujral S, Sinha S, Sison C, Ten S & Maclaren NK. Insulin-like growth factor binding protein-1 to screen for insulin resistance in children. Diabetes Technology and Therapeutics 2007 9 43-51. (doi:10.1089/dia.2006.0056)
38. Maddux BA, Chan A, De Filippis EA, Mandarino LJ & Goldfine ID. IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 2006 29 1535-1537. (doi:10.2337/dc05-1367)
39. Schreiner F, Gohlke B, Stutte S, Bartmann P & Woelfle J. Growth hormone receptor d3-variant, insulin-like growth factor binding protein-1 575G/A polymorphism and postnatal catch-up growth: association with parameters of glucose homeostasis in former extremely low birth weight preterm infants. Growth Hormone and IGF Research 2010 20 201-204. (doi:10.1016/j.ghir.2010.01.002)
40. Delafontaine P, Song YH & Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 435-444. (doi:10.1161/01.ATV. 0000105902.89459.09)
41. Conover CA, Harrington SC & Bale LK. Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Hormone & IGF Research 2008 18 213-220. (doi:10.1016/j.ghir.2007.09.001)
42. Conover CA & Bale LK. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 2007 6 727-729. (doi:10.1111/j.1474-9726. 2007.00328.x)
43. Resch ZT, Simari RD & Conover CA. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology 2006 147 5634-5640. (doi:10.1210/en.2006-0493)
44. Conover CA, Bale LK, Mader JR, Mason MA, Keenan KP & Marler RJ. Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2010 65 590-599. (doi:10.1093/gerona/glq032)
45. Andreotti F, Rio T & Conti E. Role of PAPP-A in atherothrombosis: messages to take home. Atherosclerosis 2009 203 353-354. (doi:10.1016/j. atherosclerosis.2008.09.024)
46. Higashi Y, Sukhanov S, Anwar A, Shai SY & Delafontaine P. IGF-1, oxidative stress and atheroprotection. Trends in Endocrinology and Metabolism 2010 21 245-254. (doi:10.1016/j.tem.2009.12.005)